Efficacy and safety of fast-acting insulin aspart in adults with type 2 diabetes with different insulin requirements

被引：0
|
作者：
Sesti, G. [1 ]
Lane, W. [2 ]
Ekelund, M. [3 ]
Thorisdottir, O. [3 ]
Jodar, E. [4 ]
Oviedo, A. [5 ,6 ]
Rathor, N. [7 ]
Senior, P. [8 ]
Franek, E. [9 ,10 ]
机构：
[1] Sapienza Univ Rome, Dept Clin & Mol Med, Rome, Italy
[2] Mt Diabet & Endocrine Ctr, Asheville, NC USA
[3] Novo Nordisk AS, Soborg, Denmark
[4] Univ Europea, Univ Hosp Quironsalud Madrid, Madrid, Spain
[5] Santojanni Hosp, Buenos Aires, DF, Argentina
[6] Cenudiab, Buenos Aires, DF, Argentina
[7] Novo Nordisk Serv Ctr India Private Ltd, Bangalore, Karnataka, India
[8] Univ Alberta, Div Endocrinol & Metab, Edmonton, AB, Canada
[9] Polish Acad Sci, Mossakowski Med Res Ctr, Warsaw, Poland
[10] CSK MSWiA, Dept Endocrinol & Diabetol, Warsaw, Poland
来源：
DIABETOLOGIA | 2020年 / 63卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
684
引用
收藏
页码：S330 / S330
页数：1
相关论文
共 50 条
  • [31] Improved glycaemic control with carbohydrate counting for adjustment of fast-acting insulin aspart versus insulin aspart in subjects with type 1 diabetes
    Philis-Tsimikas, A.
    Bode, B. W.
    Franek, E.
    Rose, L.
    Buchholtz, K.
    Demissie, M.
    Pieber, T. R.
    [J]. DIABETOLOGIA, 2017, 60 : S315 - S315
  • [32] Improved glycaemic control with carbohydrate counting for adjustment of fast-acting insulin aspart vs insulin aspart in subjects with Type 1 diabetes
    Leelarathna, L.
    Philis-Tsimikas, A.
    Bode, B. W.
    Franek, E.
    Rose, L.
    Buchholtz, K.
    Pieber, T. R.
    [J]. DIABETIC MEDICINE, 2018, 35 : 19 - 19
  • [33] Efficacy and safety of fast-acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): A 52-week, randomized, treat-to-target, phase III trial
    Mathieu, Chantal
    Bode, Bruce W.
    Franek, Edward
    Philis-Tsimikas, Athena
    Rose, Ludger
    Graungaard, Tina
    Osterskov, Anne Birk
    Russell-Jones, David
    [J]. DIABETES OBESITY & METABOLISM, 2018, 20 (05): : 1148 - 1155
  • [34] FAST-ACTING INSULIN ASPART COMPARED WITH RAPID-ACTING INSULIN ANALOGS IN THE ADVANCED HYBRID CLOSED-LOOP SYSTEM IN ADULTS WITH TYPE 1 DIABETES
    Amuedo, S.
    Herguido, N. Gros
    Bellido, V.
    Gallardo, G. Lopez
    Vinau, F. Losada
    Morales, A. Perez
    Moreno, A. Soto
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A104 - A105
  • [35] Improved Glycemic Control with Carbohydrate Counting for Adjustment of Fast-Acting Insulin Aspart vs. Insulin Aspart in Subjects with Type 1 Diabetes
    Philis-Tsimikas, Athena
    Bode, Bruce W.
    Franek, Edward
    Rose, Ludger
    Buchholtz, Kristine
    Demissie, Marek
    Pieber, Thomas R.
    [J]. DIABETES, 2017, 66 : A260 - A260
  • [36] Clinical Pharmacology of Fast-Acting Insulin Aspart Versus Insulin Aspart Measured as Free or Total Insulin Aspart and the Relation to Anti-Insulin Aspart Antibody Levels in Subjects with Type 1 Diabetes Mellitus
    Haahr, Hanne
    Pieber, Thomas R.
    Mathieu, Chantal
    Gondolf, Theis
    Shiramoto, Masanari
    Erichsen, Lars
    Heise, Tim
    [J]. CLINICAL PHARMACOKINETICS, 2019, 58 (05) : 639 - 649
  • [37] Fast-acting insulin aspart in people with type 2 diabetes: Earlier onset and greater initial exposure and glucose-lowering effect compared with insulin aspart
    Pieber, Thomas R.
    Svehlikova, Eva
    Brunner, Martina
    Halberg, Inge B.
    Thomsen, Karen Margrete Due
    Haahr, Hanne
    [J]. DIABETES OBESITY & METABOLISM, 2019, 21 (09): : 2068 - 2075
  • [38] Clinical Pharmacology of Fast-Acting Insulin Aspart Versus Insulin Aspart Measured as Free or Total Insulin Aspart and the Relation to Anti-Insulin Aspart Antibody Levels in Subjects with Type 1 Diabetes Mellitus
    Hanne Haahr
    Thomas R. Pieber
    Chantal Mathieu
    Theis Gondolf
    Masanari Shiramoto
    Lars Erichsen
    Tim Heise
    [J]. Clinical Pharmacokinetics, 2019, 58 : 639 - 649
  • [39] Use of fast-acting insulin aspart in insulin pump therapy in clinical practice
    Evans, Mark
    Ceriello, Antonio
    Danne, Thomas
    De Block, Christophe
    DeVries, J. Hans
    Lind, Marcus
    Mathieu, Chantal
    Norgaard, Kirsten
    Renard, Eric
    Wilmot, Emma G.
    [J]. DIABETES OBESITY & METABOLISM, 2019, 21 (09): : 2039 - 2047
  • [40] The association between anti-insulin aspart antibodies and the pharmacokinetic and pharmacodynamic characteristics of fast-acting insulin aspart in children and adolescents with type 1 diabetes
    Biester, Torben
    von Dem Berge, Thekla
    Bendtsen, Line Quist
    Bendtsen, Mette Dahl
    Rathor, Naveen
    Danne, Thomas
    Haahr, Hanne
    [J]. PEDIATRIC DIABETES, 2020, 21 (05) : 781 - 790
12345